Shigeki Nakamura

5.9k total citations
206 papers, 4.3k citations indexed

About

Shigeki Nakamura is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shigeki Nakamura has authored 206 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Epidemiology, 64 papers in Infectious Diseases and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shigeki Nakamura's work include Antifungal resistance and susceptibility (39 papers), Pneumonia and Respiratory Infections (36 papers) and Fungal Infections and Studies (32 papers). Shigeki Nakamura is often cited by papers focused on Antifungal resistance and susceptibility (39 papers), Pneumonia and Respiratory Infections (36 papers) and Fungal Infections and Studies (32 papers). Shigeki Nakamura collaborates with scholars based in Japan, United States and Pakistan. Shigeki Nakamura's co-authors include Yoshitaka Yamamura, Toyoki Mori, Kimberly M. Davis, Jeffrey N. Weiser, Katsunori Yanagihara, Koichi Izumikawa, Toshiyuki Onogawa, Shigeru Kohno, Michiaki Tominaga and Hidenori Ogawa and has published in prestigious journals such as Science, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Shigeki Nakamura

200 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeki Nakamura Japan 31 1.4k 1.3k 1.2k 844 629 206 4.3k
Bengt Åndersson Sweden 36 1.1k 0.8× 724 0.6× 1.0k 0.9× 258 0.3× 63 0.1× 122 4.5k
Xin Su China 46 1.2k 0.9× 581 0.4× 1.7k 1.5× 1.3k 1.5× 48 0.1× 267 8.4k
Kenneth J. Holroyd United States 34 390 0.3× 707 0.5× 943 0.8× 292 0.3× 96 0.2× 65 4.5k
William P. Hausdorff United States 35 3.3k 2.5× 495 0.4× 2.8k 2.4× 398 0.5× 108 0.2× 104 7.2k
Gerene M. Denning United States 38 689 0.5× 1.7k 1.3× 2.2k 1.9× 220 0.3× 40 0.1× 137 6.0k
Momtchilo Russo Brazil 40 1.0k 0.8× 366 0.3× 793 0.7× 432 0.5× 44 0.1× 119 4.5k
Nobuyuki Kobayashi Japan 44 1.2k 0.9× 1.1k 0.9× 2.0k 1.7× 621 0.7× 30 0.0× 315 7.1k
Florian Obermeier Germany 41 1.1k 0.8× 174 0.1× 1.9k 1.6× 422 0.5× 210 0.3× 95 5.7k
Robert A. Nicholas United States 44 674 0.5× 211 0.2× 2.5k 2.1× 393 0.5× 65 0.1× 137 6.7k
David A. Clark Canada 59 807 0.6× 792 0.6× 1.5k 1.2× 208 0.2× 122 0.2× 256 11.2k

Countries citing papers authored by Shigeki Nakamura

Since Specialization
Citations

This map shows the geographic impact of Shigeki Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeki Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeki Nakamura more than expected).

Fields of papers citing papers by Shigeki Nakamura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeki Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeki Nakamura. The network helps show where Shigeki Nakamura may publish in the future.

Co-authorship network of co-authors of Shigeki Nakamura

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeki Nakamura. A scholar is included among the top collaborators of Shigeki Nakamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeki Nakamura. Shigeki Nakamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Hiroshi, Kimiko Ubukata, Kiyofumi Ohkusu, et al.. (2025). S. suis serotype 2 meningitis in a patient with horse contact in a Japanese stable: A case report. Diagnostic Microbiology and Infectious Disease. 112(4). 116868–116868.
2.
Chen, Pengwen, et al.. (2024). A novel fungal-targeted drug delivery system dectin-1-targeted-PEG-amino acid polymer block enhances antifungal activity and reduces cytotoxicity of amphotericin B. Journal of Drug Delivery Science and Technology. 100. 106073–106073. 5 indexed citations
3.
Nakamura, Shigeki, Masashi Mikami, Naohiro Yonemoto, et al.. (2024). Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan. Expert Review of Vaccines. 23(1). 546–560. 2 indexed citations
4.
Shinohara, Koh, Shigeki Nakamura, Yoshitsugu Miyazaki, et al.. (2024). Micafungin-breakthrough Coniochaeta hoffmannii (Lecythophora hoffmannii) fungemia following cord blood transplant in a patient with acute myeloid leukemia successfully treated with voriconazole. Journal of Infection and Chemotherapy. 30(9). 934–937.
5.
Iwanaga, Naoki, Yuya Ito, Nobuyuki Ashizawa, et al.. (2023). Pulmonary Coccidioidomycosis Complicated by Nontuberculous Mycobacterial Pulmonary Diseases with a Literature Review. Japanese Journal of Infectious Diseases. 76(5). 314–318. 1 indexed citations
6.
Nagi, Minoru, Koichi Tanabe, Kazuko Tanaka, et al.. (2022). Exhibition of antifungal resistance by sterol-auxotrophic strains ofCandida glabratawith intact virulence. JAC-Antimicrobial Resistance. 4(1). dlac018–dlac018. 2 indexed citations
7.
Umeyama, Takashi, Yuta Hayashi, Satoshi Yamagoe, et al.. (2018). CRISPR/Cas9 Genome Editing To Demonstrate the Contribution of Cyp51A Gly138Ser to Azole Resistance in Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 62(9). 28 indexed citations
8.
Kimura, Muneyoshi, Hideki Araoka, Shinsuke Takagi, et al.. (2018). Cryptococcal meningitis following umbilical cord blood transplantation, association between the occurrence of cryptococcal infection and tacrolimus discontinuation among allogeneic hematopoietic stem cell recipients. Journal of Infection and Chemotherapy. 25(4). 289–292. 7 indexed citations
9.
Miyazaki, Taiga, Shintaro Shimamura, Hironobu Nakayama, et al.. (2017). Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species. PLoS ONE. 12(7). e0180990–e0180990. 14 indexed citations
10.
Murakami, Chikako, et al.. (2014). Analysis of gene mutations encoding sarcomeric proteins in sudden death cases caused by cardiomyopathy. 44(1). 47–55. 1 indexed citations
11.
Izumikawa, Koichi, Koichi Izumikawa, Takahiro Takazono, et al.. (2013). Clinical features, risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia: A review of the Japanese literature. Journal of Infection and Chemotherapy. 20(3). 181–185. 74 indexed citations
12.
Nakamura, Shigeki, Masafumi Seki, Kenji Fukudome, et al.. (2013). Toll-Like Receptor 4 Agonistic Antibody Promotes Innate Immunity against Severe Pneumonia Induced by Coinfection with Influenza Virus and Streptococcus pneumoniae. Clinical and Vaccine Immunology. 20(7). 977–985. 23 indexed citations
13.
Mihara, Tomo, Koichi Izumikawa, Hiroshi Kakeya, et al.. (2012). Multilocus sequence typing ofCryptococcus neoformansin non-HIV associated cryptococcosis in Nagasaki, Japan. Medical Mycology. 51(3). 252–260. 41 indexed citations
14.
Sasaki, Chizuko, Tatsuo Shinozuka, Chikako Murakami, et al.. (2012). Simultaneous determination of 5 psychotropic drugs of various types in an autopsy case of acute multiple drug poisoning. Forensic Science International. 227(1-3). 90–94. 12 indexed citations
15.
Nakamura, Shigeki, et al.. (2011). Mutational analysis of the mitochondrial DNA detected in sudden cardiac death caused by cardiomyopathy. 41(2). 127–135. 3 indexed citations
16.
Nakamura, Shigeki, Mikhail Shchepetov, Ankur B. Dalia, et al.. (2011). Molecular Basis of Increased Serum Resistance among Pulmonary Isolates of Non-typeable Haemophilus influenzae. PLoS Pathogens. 7(1). e1001247–e1001247. 70 indexed citations
17.
Nakamura, Shigeki, Katsunori Yanagihara, Koichi Yamada, et al.. (2011). High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells. European Journal of Pharmacology. 659(1). 67–71. 10 indexed citations
18.
Nakamura, Shigeki, et al.. (2001). Squamous Cell Carcinoma of the Stomach with Multiple Liver Metastases: A Case Report.. The Japanese Journal of Gastroenterological Surgery. 34(8). 1299–1302. 2 indexed citations
19.
Yamamura, Yoshitaka, Hidenori Ogawa, Hiroshi Yamashita, et al.. (1992). Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. British Journal of Pharmacology. 105(4). 787–791. 292 indexed citations
20.
Nakamura, Shigeki, et al.. (1990). HIP-produced bimetallic cylinder for plastic molding machines. 24–28. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026